{
    "type": "ETN",
    "ucits": false,
    "replication_method": "synthetic",
    "swaps": true,
    "derivatives": true,
    "leverage": false,
    "inverse": false,
    "complex_factors": [
        "Synthetic replication via swap agreements",
        "Counterparty risk exposure",
        "Complex underlying index (UBS CMCI Composite)",
        "Open-ended structured note with contingent exercise features"
    ],
    "classification": "complex",
    "supporting_data": "The product is an Open End Tracker Certificate (ETN) issued by UBS AG, linked to the UBS CMCI Composite GBP Monthly Hedged Total Return index. It is not a UCITS fund but a structured debt instrument. The KIID explicitly states that the product is 'not simple and may be difficult to understand,' indicating complexity. The product does not confer ownership rights in the underlying index components and relies on a predefined exercise procedure to realize returns, which is typical of synthetic replication structures. The underlying index is a commodity index (CMCI Composite) that is known to use futures contracts and may involve roll costs, contango, and backwardation effects, adding complexity. The product exposes investors to counterparty risk of UBS AG, as it is a debt instrument dependent on the issuer's ability to pay. The KIID mentions management fees and the possibility of early termination by the issuer under extraordinary events, which can lead to significant losses. The risk indicator is medium (4/7), but the product carries risks of total capital loss and liquidity constraints. The PRIIPs KID and the product factsheet (not fully provided here) typically confirm the use of derivatives and swap agreements to synthetically replicate the index performance. There is no leverage or inverse exposure, but the synthetic replication, counterparty risk, and structured note features classify this product as complex under MiFID II. The product requires advanced investor knowledge and is not suitable for all retail investors."
}